Clinical Trials in Atlanta

Showing 12021-12040 of 19,805 trials

The Morehouse-Emory Cardiovascular Center for Health Equity Study: Clinical Intervention Project

NCT03308812

This study will recruit from participants in the Morehouse-Emory Cardiovascular (MECA) study for a clinical intervention examining cardiac outcomes between participants who are randomized to received Health360x (a web-based and mobile-based application) or Health360x plus personalized health coaching. Participants will receive instruction on using the Health360x application and will use Health360x alone or Health360x with a health coach for 6 months. Measures of cardiovascular health will be assessed at baseline and after the 6 month long intervention.

Cardiovascular Diseases

Emory University150 participantsStarted Jul 2017

Atlanta, Georgia, United States • Atlanta, Georgia, United States • Atlanta, Georgia, United States

COMPLETEDPhase 3< 1 mile

New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects

NCT00044577

A 48-week study to investigate the safety and effectiveness of a new compact formulation of two already FDA-approved anti-HIV drugs in subjects who have already been receiving treatment for their HIV infection.

Infection, Human Immunodeficiency Virus IHIV Infection

ViiV Healthcare166 participantsStarted Jul 2002

Los Angeles, California, United States • Oakland, California, United States • Fort Lauderdale, Florida, United States +73 more locations

The Morehouse-Emory Cardiovascular Center for Health Equity Study: Clinical Intervention Project

New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects

Find Trials by Condition in Atlanta

Lung-MAP: Rilotumumab and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches

A Study Of PF-05082566 As A Single Agent And In Combination With Rituximab

Novel Endoluminal Clinical TreAtment of Reflux

A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease

Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast Cancer

A Study of Prexasertib (LY2606368) in Participants With Extensive Stage Disease Small Cell Lung Cancer

Study of Ataluren (PTC124) in Cystic Fibrosis

A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitus With Nasal Polyps

Office-based Vision Therapy for Improving Reading and Attention in Children With Convergence Insufficiency

STP206 for the Prevention of Necrotizing Enterocolitis (NEC)

A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus

Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation

Genetic Analysis of Hereditary Prostate Cancer

A Study of B-701 in Combination With Pembrolizumab in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma

A Study of Rovalpituzumab Tesirine (SC16LD6.5) in the Frontline Treatment of Patients With Extensive Stage Small Cell Lung Cancer

Single-Ascending-Dose Study of BIIB076 in Healthy Volunteers and Participants With Alzheimer's Disease

Tramadol Versus Placebo in the Management of Postoperative Pain Following Bunionectomy

The Effect of BMS-986195 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Patients